VIR insider transaction filings
Vir Biotechnology, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-12. Screen VIR transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-12 | 4 | MORE ROBERT J — Director | Other (J): 8,000 @ $0 · Other (J): 8,000 @ $0 | EDGAR |
| 2026-06-10 | 4 | Coughlin Timothy — Director | Grant/award (A): 8,000 @ $0 · Grant/award (A): 8,000 @ $0 · Grant/award (A): 16,000 (derivative) @ $0 · Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2026-06-02 | 4 | Napolitano Janet — Director | Sale (S): 3,200 @ $9.45 | EDGAR |
| 2026-06-02 | 4 | Sabatini Brent — SVP, Chief Accounting Officer | Sale (S): 379 @ $9.45 | EDGAR |
| 2026-05-28 | 4 | Napolitano Janet — Director | Grant/award (A): 8,000 @ $0 · Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2026-05-28 | 4 | Farid Ramy — Director | Grant/award (A): 8,000 @ $0 · Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2026-05-28 | 4 | Sigal Charles Elliott — Director | Grant/award (A): 8,000 @ $0 · Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2026-05-28 | 4 | Hatfield Jeffrey S. — Director | Grant/award (A): 8,000 @ $0 · Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2026-05-28 | 4 | MORE ROBERT J — Director | Grant/award (A): 8,000 @ $0 · Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2026-05-28 | 4 | BISCHOFBERGER NORBERT W — Director | Grant/award (A): 8,000 @ $0 · Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | SATO VICKI L — Director | Sale (S): 22,000 @ $10.05 | EDGAR |
| 2026-04-30 | 4 | De Backer Marianne — President and CEO, Director | Other (J): 233,532 @ $0 · Other (J): 233,532 @ $0 | EDGAR |
| 2026-04-07 | 4 | De Backer Marianne — President and CEO, Director | Sale (S): 72,559 @ $9.16 | EDGAR |
| 2026-04-02 | 4 | SATO VICKI L — Director | Sale (S): 22,000 @ $9.07 | EDGAR |
| 2026-03-24 | 4 | Sabatini Brent — SVP, Chief Accounting Officer | Sale (S): 7,711 @ $9.12 | EDGAR |
| 2026-03-23 | 4 | O'Byrne Jason — EVP & Chief Financial Officer | Other (J): 2,500 @ $0 · Other (J): 2,500 @ $0 | EDGAR |
| 2026-03-03 | 4 | SATO VICKI L — Director | Sale (S): 21,800 @ $9.50 · Sale (S): 200 @ $9.98 | EDGAR |
| 2026-02-26 | 4 | Sabatini Brent — SVP, Chief Accounting Officer | Sale (S): 1,430 @ $9.53 | EDGAR |
| 2026-02-26 | 4 | O'Byrne Jason — EVP & Chief Financial Officer | Sale (S): 1,634 @ $9.53 | EDGAR |
| 2026-02-26 | 4 | Eisner Mark — EVP and Chief Medical Officer | Sale (S): 1,616 @ $9.53 · Sale (S): 1,889 @ $9.82 | EDGAR |
| 2026-02-26 | 4 | de Verneuil Vanina — EVP, General Counsel, Corp Sec | Sale (S): 3,117 @ $9.53 · Sale (S): 13,700 @ $9.82 | EDGAR |
| 2026-02-26 | 4 | De Backer Marianne — Chief Executive Officer, Director | Sale (S): 14,762 @ $9.53 | EDGAR |
| 2026-02-26 | 4 | SATO VICKI L — Director | Option exercise (M): 42,377 @ $1.49 · Sale (S): 42,177 @ $9.75 · Sale (S): 200 @ $10.26 · Option exercise (M): 42,377 (derivative) @ $0 | EDGAR |
| 2026-02-24 | 4 | Sabatini Brent — SVP, Chief Accounting Officer | Grant/award (A): 25,000 @ $0 · Sale (S): 1,829 @ $7.45 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-02-24 | 4 | O'Byrne Jason — EVP & Chief Financial Officer | Grant/award (A): 55,000 @ $0 · Sale (S): 2,089 @ $7.45 · Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2026-02-24 | 4 | Eisner Mark — EVP and Chief Medical Officer | Grant/award (A): 55,000 @ $0 · Sale (S): 2,089 @ $7.45 · Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2026-02-24 | 4 | de Verneuil Vanina — EVP, General Counsel, Corp Sec | Grant/award (A): 55,000 @ $0 · Sale (S): 4,445 @ $7.45 · Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2026-02-24 | 4 | De Backer Marianne — Chief Executive Officer, Director | Grant/award (A): 285,000 @ $0 · Sale (S): 19,039 @ $7.45 · Grant/award (A): 570,000 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | Sabatini Brent — SVP, Chief Accounting Officer | Sale (S): 1,530 @ $7.79 | EDGAR |
| 2026-02-03 | 4 | SATO VICKI L — Director | Sale (S): 22,000 @ $7.71 | EDGAR |
| 2026-01-05 | 4 | SATO VICKI L — Director | Sale (S): 22,000 @ $5.93 | EDGAR |
| 2025-12-03 | 4 | SVF Endurance (Cayman) Ltd — 10% owner SOFTBANK VISION FUND (AIV M1) L.P. — 10% owner SB INVESTMENT ADVISERS (UK) LTD — 10% owner | Sale (S): 191,854 @ $5.98 | EDGAR |
| 2025-12-02 | 4 | SATO VICKI L — Director | Sale (S): 22,000 @ $6.00 | EDGAR |
| 2025-12-01 | 4 | SVF Endurance (Cayman) Ltd — 10% owner SOFTBANK VISION FUND (AIV M1) L.P. — 10% owner SB INVESTMENT ADVISERS (UK) LTD — 10% owner | Sale (S): 127,938 @ $6.39 · Sale (S): 61,493 @ $6.44 | EDGAR |
| 2025-11-26 | 4 | SVF Endurance (Cayman) Ltd — 10% owner SOFTBANK VISION FUND (AIV M1) L.P. — 10% owner SB INVESTMENT ADVISERS (UK) LTD — 10% owner | Sale (S): 227,803 @ $6.15 · Sale (S): 235,971 @ $6.38 | EDGAR |
| 2025-11-18 | 4 | O'Byrne Jason — EVP & Chief Financial Officer | Sale (S): 6,799 @ $5.56 | EDGAR |
| 2025-11-07 | 4 | de Verneuil Vanina — EVP, General Counsel, Corp Sec | Sale (S): 2,385 @ $5.16 | EDGAR |
| 2025-11-04 | 4 | de Verneuil Vanina — EVP and General Counsel | Sale (S): 1,365 @ $5.86 | EDGAR |
| 2025-11-04 | 4 | SATO VICKI L — Director | Sale (S): 22,000 @ $5.64 | EDGAR |
| 2025-10-30 | 4 | SVF Endurance (Cayman) Ltd — 10% owner SOFTBANK VISION FUND (AIV M1) L.P. — 10% owner SB INVESTMENT ADVISERS (UK) LTD — 10% owner | Sale (S): 24,453 @ $6.50 · Sale (S): 100 @ $6.49 | EDGAR |
| 2025-10-28 | 4 | SVF Endurance (Cayman) Ltd — 10% owner SOFTBANK VISION FUND (AIV M1) L.P. — 10% owner SB INVESTMENT ADVISERS (UK) LTD — 10% owner | Sale (S): 46,696 @ $5.96 · Sale (S): 66,403 @ $6.05 | EDGAR |
| 2025-10-24 | 4 | SVF Endurance (Cayman) Ltd — 10% owner SOFTBANK VISION FUND (AIV M1) L.P. — 10% owner SB INVESTMENT ADVISERS (UK) LTD — 10% owner | Sale (S): 144,266 @ $6.15 · Sale (S): 154,383 @ $5.99 | EDGAR |
| 2025-10-22 | 4 | SVF Endurance (Cayman) Ltd — 10% owner SOFTBANK VISION FUND (AIV M1) L.P. — 10% owner SB INVESTMENT ADVISERS (UK) LTD — 10% owner | Sale (S): 220,535 @ $6.20 · Sale (S): 109,675 @ $6.30 | EDGAR |
| 2025-10-17 | 4 | SVF Endurance (Cayman) Ltd — 10% owner SOFTBANK VISION FUND (AIV M1) L.P. — 10% owner SB INVESTMENT ADVISERS (UK) LTD — 10% owner | Sale (S): 16,671 @ $6.07 · Sale (S): 12,844 @ $6.10 | EDGAR |
| 2025-10-14 | 4 | SVF Endurance (Cayman) Ltd — 10% owner SOFTBANK VISION FUND (AIV M1) L.P. — 10% owner SB INVESTMENT ADVISERS (UK) LTD — 10% owner | Sale (S): 249,060 @ $6.14 · Sale (S): 2,300 @ $6.08 | EDGAR |
| 2025-10-09 | 4 | SVF Endurance (Cayman) Ltd — 10% owner SOFTBANK VISION FUND (AIV M1) L.P. — 10% owner SB INVESTMENT ADVISERS (UK) LTD — 10% owner | Sale (S): 72,133 @ $5.60 · Sale (S): 466,242 @ $6.05 | EDGAR |
| 2025-10-07 | 4 | SVF Endurance (Cayman) Ltd — 10% owner SOFTBANK VISION FUND (AIV M1) L.P. — 10% owner SB INVESTMENT ADVISERS (UK) LTD — 10% owner | Sale (S): 450,342 @ $5.56 · Sale (S): 73,955 @ $5.69 | EDGAR |
| 2025-10-02 | 4 | SATO VICKI L — Director | Sale (S): 22,000 @ $5.84 | EDGAR |
| 2025-09-03 | 4 | SATO VICKI L — Director | Sale (S): 22,000 @ $4.99 | EDGAR |
| 2025-08-04 | 4 | SATO VICKI L — Director | Sale (S): 22,000 @ $4.99 | EDGAR |
Recent 8-K events — Vir Biotechnology, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-24 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-06-10 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-05-28 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-10 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-03-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-03-02 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-02-26 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-23 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.02 — Results of Operations and Financial Condition 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=VIR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →